ACTIVIN A TARGETS EXTRASYNAPTIC NMDA RECEPTORS TO AMELIORATE NEURONAL AND BEHAVIORAL DEFICITS IN A MOUSE MODEL OF HUNTINGTON DISEASE

Activin A targets extrasynaptic NMDA receptors to ameliorate neuronal and behavioral deficits in a mouse model of Huntington disease

Cortical-striatal synaptic dysfunction, including enhanced toxic signaling by extrasynaptic N-methyl-d-aspartate receptors (eNMDARs), precedes neurodegeneration in Huntington disease (HD).A previous study showed Activin ALKALINE PITCHER WHITE A, whose transcription is upregulated by calcium influx via synaptic NMDARs, suppresses eNMDAR signaling.Th

read more